Newamsterdam Pharma Co NV

Newamsterdam Pharma insider activity: CFO’s sell‑to‑cover sale vs. new RSU and option grants shows confidence, low dilution and potential upside tied to clinical milestones.

Newamsterdam Pharma insider trades show executive confidence, aligning RSU and option moves with long‑term growth and a rising small‑molecule pipeline.